{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:07:08Z","timestamp":1761894428140},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2007,2,1]]},"DOI":"10.1038\/sj.npp.1301225","type":"journal-article","created":{"date-parts":[[2006,10,31]],"date-time":"2006-10-31T14:47:00Z","timestamp":1162306020000},"page":"458-470","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["A Prospective Cohort Study on Sustained Effects of Low-Dose Ecstasy Use on the Brain in New Ecstasy Users"],"prefix":"10.1038","volume":"32","author":[{"given":"Maartje M L","family":"de Win","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesbeth","family":"Reneman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerry","family":"Jager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik-Jan P","family":"Vlieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00edlvia D","family":"Olabarriaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Lavini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Bisschops","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles B L M","family":"Majoie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Booij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard J","family":"den Heeten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"van den Brink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,11,1]]},"reference":[{"key":"BF1301225_CR1","first-page":"794","volume":"23","author":"K Arfanakis","year":"2002","unstructured":"Arfanakis K, Haughton VM, Carew JD, Rogers BP, Dempsey RJ, Meyerand ME (2002). Diffusion tensor MR imaging in diffuse axonal injury. AJNR Am J Neuroradiol 23: 794\u2013802.","journal-title":"AJNR Am J Neuroradiol"},{"key":"BF1301225_CR2","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961). An inventory for measuring depression. Arch Gen Psychiatry 4: 561\u2013571.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1301225_CR3","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/mrm.1910140311","volume":"14","author":"JW Belliveau","year":"1990","unstructured":"Belliveau JW, Rosen BR, Kantor HL, Rzedzian RR, Kennedy DN, McKinstry RC et al (1990). Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med 14: 538\u2013546.","journal-title":"Magn Reson Med"},{"key":"BF1301225_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1176\/pn.40.2.00400046a","volume":"40","author":"E Bender","year":"2005","unstructured":"Bender E (2005). FDA approves study of ecstasy in some terminally ill patients. Psychiatric News 40: 46.","journal-title":"Psychiatric News"},{"key":"BF1301225_CR5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/mrm.10690","volume":"51","author":"N Bodammer","year":"2004","unstructured":"Bodammer N, Kaufmann J, Kanowski M, Tempelmann C (2004). Eddy current correction in diffusion-weighted imaging using pairs of images acquired with opposite diffusion gradient polarity. Magn Reson Med 51: 188\u2013193.","journal-title":"Magn Reson Med"},{"key":"BF1301225_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00213-003-1585-9","volume":"171","author":"AJ Bond","year":"2004","unstructured":"Bond AJ, Verheyden SL, Wingrove J, Curran HV (2004). Angry cognitive bias, trait aggression and impulsivity in substance users. Psychopharmacology 171: 331\u2013339.","journal-title":"Psychopharmacology"},{"key":"BF1301225_CR7","first-page":"1030","volume":"22","author":"A Bozzao","year":"2001","unstructured":"Bozzao A, Floris R, Baviera ME, Apruzzese A, Simonetti G (2001). Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. AJNR Am J Neuroradiol 22: 1030\u20131036.","journal-title":"AJNR Am J Neuroradiol"},{"key":"BF1301225_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3109\/02841859909175552","volume":"40","author":"S Brockstedt","year":"1999","unstructured":"Brockstedt S, Borg M, Geijer B, Wirestam R, Thomsen C, Holtas S et al (1999). Triggering in quantitative diffusion imaging with single-shot EPI. Acta Radiol 40: 263\u2013269.","journal-title":"Acta Radiol"},{"key":"BF1301225_CR9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/00006231-200108000-00007","volume":"22","author":"R Buchert","year":"2001","unstructured":"Buchert R, Obrocki J, Thomasius R, Vaterlein O, Petersen K, Jenicke L et al (2001). Long-term effects of \u2018ecstasy\u2019 abuse on the human brain studied by FDG PET. Nucl Med Commun 22: 889\u2013897.","journal-title":"Nucl Med Commun"},{"key":"BF1301225_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1176\/appi.ajp.161.7.1181","volume":"161","author":"R Buchert","year":"2004","unstructured":"Buchert R, Thomasius R, Wilke F, Petersen K, Nebeling B, Obrocki J et al (2004). A voxel-based PET investigation of the long-term effects of \u2018ecstasy\u2019 consumption on brain serotonin transporters. Am J Psychiatry 161: 1181\u20131189.","journal-title":"Am J Psychiatry"},{"key":"BF1301225_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.drugalcdep.2004.04.003","volume":"76","author":"GK Butler","year":"2004","unstructured":"Butler GK, Montgomery AM (2004). Impulsivity, risk taking and recreational \u2018ecstasy\u2019 (MDMA) use. Drug Alcohol Depend 76: 55\u201362.","journal-title":"Drug Alcohol Depend"},{"key":"BF1301225_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/00004714-200008000-00010","volume":"20","author":"J Cam\u00ed","year":"2000","unstructured":"Cam\u00ed J, Farr\u00e9 M, Mas M, Roset PN, Poudevida S, Mas A et al (2000). Human pharmacology of 3,4-methylenedioxymethamphetamine (\u2018ecstasy\u2019): psychomotor performance and subjective effects. J Clin Psychopharmacol 20: 455\u2013466.","journal-title":"J Clin Psychopharmacol"},{"key":"BF1301225_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1191\/1352458504ms997oa","volume":"10","author":"E Cassol","year":"2004","unstructured":"Cassol E, Ranjeva JP, Ibarrola D, Mekies C, Manelfe C, Clanet M et al (2004). Diffusion tensor imaging in multiple sclerosis: a tool for monitoring changes in normal-appearing white matter. Mult Scler 10: 188\u2013196.","journal-title":"Mult Scler"},{"key":"BF1301225_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/(SICI)1522-2586(199910)10:4<521::AID-JMRI4>3.0.CO;2-9","volume":"10","author":"L Chang","year":"1999","unstructured":"Chang L, Ernst T, Grob CS, Poland RE (1999). Cerebral 1H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, \u2018ecstasy\u2019) users. J Magn Reson Imaging 10: 521\u2013526.","journal-title":"J Magn Reson Imaging"},{"key":"BF1301225_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0925-4927(02)00004-5","volume":"114","author":"L Chang","year":"2002","unstructured":"Chang L, Ernst T, Speck O, Patel H, DeSilva M, Leonido-Yee M et al (2002). Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res 114: 65\u201379.","journal-title":"Psychiatry Res"},{"key":"BF1301225_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0925-4927(99)00048-7","volume":"98","author":"L Chang","year":"2000","unstructured":"Chang L, Grob CS, Ernst T, Itti L, Mishkin FS, Jose-Melchor R et al (2000). Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study. Psychiatry Res 98: 15\u201328.","journal-title":"Psychiatry Res"},{"key":"BF1301225_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/429126a","volume":"429","author":"E Check","year":"2004","unstructured":"Check E (2004). Psychedelic drugs: the ups and downs of ecstasy. Nature 429: 126\u2013128.","journal-title":"Nature"},{"key":"BF1301225_CR18","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/00004728-200009000-00013","volume":"24","author":"CY Chen","year":"2000","unstructured":"Chen CY, Lee KW, Lee CC, Chin SC, Chung HW, Zimmerman RA (2000). Heroin-induced spongiform leukoencephalopathy: value of diffusion MR imaging. J Comput Assist Tomogr 24: 735\u2013737.","journal-title":"J Comput Assist Tomogr"},{"key":"BF1301225_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000076536","volume":"51","author":"K Chu","year":"2004","unstructured":"Chu K, Jung KH, Kim HJ, Jeong SW, Kang DW, Roh JK (2004). Diffusion-weighted MRI and 99mTc-HMPAO SPECT in delayed relapsing type of carbon monoxide poisoning: evidence of delayed cytotoxic edema. Eur Neurol 51: 98\u2013103.","journal-title":"Eur Neurol"},{"key":"BF1301225_CR20","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988). Statistical Power Analysis for the Behavioral Sciences. Lawrence Earlbaum Associates: Hillsdale, NJ."},{"key":"BF1301225_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0301-0082(96)00033-0","volume":"50","author":"Z Cohen","year":"1996","unstructured":"Cohen Z, Bonvento G, Lacombe P, Hamel E (1996). Serotonin in the regulation of brain microcirculation. Prog Neurobiol 50: 335\u2013362.","journal-title":"Prog Neurobiol"},{"key":"BF1301225_CR22","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1111\/j.1476-5381.1995.tb15037.x","volume":"115","author":"MI Colado","year":"1995","unstructured":"Colado MI, Williams JL, Green AR (1995). The hyperthermic and neurotoxic effects of \u2018ecstasy\u2019 (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the dark agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype. Br J Pharmacol 115: 1281\u20131289.","journal-title":"Br J Pharmacol"},{"key":"BF1301225_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1148\/radiol.2211001397","volume":"221","author":"WA Copen","year":"2001","unstructured":"Copen WA, Schwamm LH, Gonzalez RG, Wu O, Harmath CB, Schaefer PW et al (2001). Ischemic stroke: effects of etiology and patient age on the time course of the core apparent diffusion coefficient. Radiology 221: 27\u201334.","journal-title":"Radiology"},{"key":"BF1301225_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neulet.2004.03.004","volume":"362","author":"J Daumann","year":"2004","unstructured":"Daumann J, Fischermann T, Pilatus U, Thron A, Moeller-Hartmann W, Gouzoulis-Mayfrank E (2004a). Proton magnetic resonance spectroscopy in ecstasy (MDMA) users. Neurosci Lett 362: 113\u2013116.","journal-title":"Neurosci Lett"},{"key":"BF1301225_CR25","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00213-003-1719-0","volume":"173","author":"J Daumann","year":"2004","unstructured":"Daumann J, Hensen G, Thimm B, Rezk M, Till B, Gouzoulis-Mayfrank E (2004b). Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional\/longitudinal investigation. Psychopharmacology 173: 398\u2013404.","journal-title":"Psychopharmacology"},{"key":"BF1301225_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/hup.342","volume":"16","author":"J Daumann","year":"2001","unstructured":"Daumann J, Pelz S, Becker S, Tuchtenhagen F, Gouzoulis-Mayfrank E (2001). Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use. Human Psychopharmacology-Clinical and Experimental 16: 627\u2013633.","journal-title":"Human Psychopharmacology-Clinical and Experimental"},{"key":"BF1301225_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/mpr.6","volume":"14","author":"MML De Win","year":"2005","unstructured":"De Win MML, Jager G, Vervaeke H, Schilt T, Reneman L, Booij J et al (2005). The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. Int J Methods in Psychiatric Research 14: 167\u2013185.","journal-title":"Int J Methods in Psychiatric Research"},{"key":"BF1301225_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1177\/0269881106063275","volume":"20","author":"MML De Win","year":"2006","unstructured":"De Win MML, Schilt T, Reneman L, Vervaeke H, Jager G, Dijkink S et al (2006). Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study. J Psychopharmacol 20: 226\u2013235.","journal-title":"J Psychopharmacol"},{"key":"BF1301225_CR29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/02791072.1986.10472366","volume":"18","author":"J Downing","year":"1986","unstructured":"Downing J (1986). The psychological and physiological effects of MDMA on normal volunteers. J Psychoactive Drugs 18: 335\u2013340.","journal-title":"J Psychoactive Drugs"},{"key":"BF1301225_CR30","unstructured":"Drugs Informatie en Monitoring Systeem (2003). Rapportage gegevens 2002. DIMS\/Trimbos-instituut: Utrecht."},{"key":"BF1301225_CR31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/hup.346","volume":"16","author":"G Dughiero","year":"2001","unstructured":"Dughiero G, Schifano F, Forza G (2001). Personality dimensions and psychopathological profiles of ecstasy users. Hum Psychopharmacol 16: 635\u2013639.","journal-title":"Hum Psychopharmacol"},{"key":"BF1301225_CR32","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1212\/WNL.54.6.1344","volume":"54","author":"T Ernst","year":"2000","unstructured":"Ernst T, Chang L, Leonido-Yee M, Speck O (2000). Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 54: 1344\u20131349.","journal-title":"Neurology"},{"key":"BF1301225_CR33","volume-title":"Handleiding bij de spanningsbehoeftelijst (SBL)","author":"JA Feij","year":"1984","unstructured":"Feij JA, van Zuilen RW (1984). Handleiding bij de spanningsbehoeftelijst (SBL). Swets & Zeitlinger: Lisse."},{"key":"BF1301225_CR34","first-page":"364","volume":"10","author":"JA Feij","year":"1982","unstructured":"Feij JA, van Zuilen RW, Gazendam A (1982). De ontwikkeling van een Nederlandse vragenlijst voor sensation seeking: de spanningsbehoeftelijst (SBL). Gedrag 10: 364\u2013383.","journal-title":"Gedrag"},{"key":"BF1301225_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0893-133X(00)00130-5","volume":"23","author":"A Gamma","year":"2000","unstructured":"Gamma A, Buck A, Berthold T, Liechti ME, Vollenweider FX (2000). 3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H215O]-PET in healthy humans. Neuropsychopharmacology 23: 388\u2013395.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301225_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00004850-199801000-00001","volume":"13","author":"G Gerra","year":"1998","unstructured":"Gerra G, Zaimovic A, Giucastro G, Maestri D, Monica C, Sartori R et al (1998). Serotonergic function after (\u00b1)3,4-methylene-dioxymethamphetamine (\u2018ecstasy\u2019) in humans. Int Clin Psychopharmacol 13: 1\u20139.","journal-title":"Int Clin Psychopharmacol"},{"key":"BF1301225_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0893-133X(99)00021-4","volume":"21","author":"HJ Gijsman","year":"1999","unstructured":"Gijsman HJ, Verkes RJ, van Gerven JM, Cohen AF (1999). MDMA study. Neuropsychopharmacology 21: 597.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301225_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejphar.2004.07.006","volume":"500","author":"AR Green","year":"2004","unstructured":"Green AR, O'shea E, Colado MI (2004). A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response. Eur J Pharmacol 500: 3\u201313.","journal-title":"Eur J Pharmacol"},{"key":"BF1301225_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/02791072.1986.10472364","volume":"18","author":"G Greer","year":"1986","unstructured":"Greer G, Tolbert R (1986). Subjective reports of the effects of MDMA in a clinical setting. J Psychoactive Drugs 18: 319\u2013327.","journal-title":"J Psychoactive Drugs"},{"key":"BF1301225_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/02791072.2002.10399948","volume":"34","author":"CS Grob","year":"2002","unstructured":"Grob CS (2002). The politics of ecstasy. J Psychoactive Drugs 34: 143\u2013144.","journal-title":"J Psychoactive Drugs"},{"key":"BF1301225_CR41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0166-4328(96)00078-2","volume":"73","author":"CS Grob","year":"1996","unstructured":"Grob CS, Poland RE, Chang L, Ernst T (1996). Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations. Behav Brain Res 73: 103\u2013107.","journal-title":"Behav Brain Res"},{"key":"BF1301225_CR42","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/mrm.1910340618","volume":"34","author":"H Gudbjartsson","year":"1995","unstructured":"Gudbjartsson H, Patz S (1995). The Rician distribution of noisy MRI data. Magn Reson Med 34: 910\u2013914.","journal-title":"Magn Reson Med"},{"key":"BF1301225_CR43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000117117","volume":"35","author":"S Hanyu","year":"1995","unstructured":"Hanyu S, Ikeguchi K, Imai H, Imai N, Yoshida M (1995). Cerebral infarction associated with 3,4-methylenedioxymethamphetamine (\u2018ecstasy\u2019) abuse. Eur Neurol 35: 173.","journal-title":"Eur Neurol"},{"key":"BF1301225_CR44","first-page":"1727","volume":"19","author":"GJ Harris","year":"1998","unstructured":"Harris GJ, Lewis RF, Satlin A, English CD, Scott TM, Yurgelun-Todd DA et al (1998). Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine. AJNR Am J Neuroradiol 19: 1727\u20131732.","journal-title":"AJNR Am J Neuroradiol"},{"key":"BF1301225_CR45","doi-asserted-by":"crossref","unstructured":"Haykin ME, Gorman M, van Hof J, Fulbright RK, aehring JM (2005). Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity. J Neurooncol.","DOI":"10.1007\/s11060-005-4569-2"},{"key":"BF1301225_CR46","first-page":"1615","volume":"24","author":"CJ Heaney","year":"2003","unstructured":"Heaney CJ, Campeau NG, Lindell EP (2003). MR imaging and diffusion-weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxicity. AJNR Am J Neuroradiol 24: 1615\u20131617.","journal-title":"AJNR Am J Neuroradiol"},{"key":"BF1301225_CR47","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1097\/00001756-200106130-00011","volume":"12","author":"ME Henry","year":"2001","unstructured":"Henry ME, Kaufman MJ, Lange N, Schmidt ME, Purcell S, Cote J et al (2001). Test-retest reliability of DSC MRI CBV mapping in healthy volunteers. Neuroreport 12: 1567\u20131569.","journal-title":"Neuroreport"},{"key":"BF1301225_CR48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0166-4328(03)00220-1","volume":"149","author":"YJ Ho","year":"2004","unstructured":"Ho YJ, Pawlak CR, Guo L, Schwarting RK (2004). Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat. Behav Brain Res 149: 135\u2013144.","journal-title":"Behav Brain Res"},{"key":"BF1301225_CR49","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1148\/radiol.2212001823","volume":"221","author":"S Hunsche","year":"2001","unstructured":"Hunsche S, Moseley ME, Stoeter P, Hedehus M (2001). Diffusion-tensor MR imaging at 1.5 and 3.0 T: initial observations. Radiology 221: 550\u2013556.","journal-title":"Radiology"},{"key":"BF1301225_CR50","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0278-5846(97)00079-1","volume":"21","author":"M Iyo","year":"1997","unstructured":"Iyo M, Namba H, Yanagisawa M, Hirai S, Yui N, Fukui S (1997). Abnormal cerebral perfusion in chronic methamphetamine abusers: a study using 99MTc-HMPAO and SPECT. Prog Neuropsychopharmacol Biol Psychiatry 21: 789\u2013796.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BF1301225_CR51","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/S0140-6736(05)66943-7","volume":"353","author":"KL Jansen","year":"1999","unstructured":"Jansen KL, Forrest AR (1999). Toxic effect of MDMA on brain serotonin neurons. Lancet 353: 1270\u20131271.","journal-title":"Lancet"},{"key":"BF1301225_CR52","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3109\/10673229709030550","volume":"4","author":"EJ Khantzian","year":"1997","unstructured":"Khantzian EJ (1997). The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry 4: 231\u2013244.","journal-title":"Harv Rev Psychiatry"},{"key":"BF1301225_CR53","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0091-3057(01)00708-0","volume":"71","author":"SJ Kish","year":"2002","unstructured":"Kish SJ (2002). How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? Pharmacol Biochem Behav 71: 845\u2013855.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1301225_CR54","volume-title":"Een nieuwe wonderpil? Verspreiding, effecten en risico's van ecstasygebruik in Amsterdam","author":"DJ Korf","year":"1991","unstructured":"Korf DJ, Blanken P, Nabben T (1991). Een nieuwe wonderpil? Verspreiding, effecten en risico's van ecstasygebruik in Amsterdam. Jellinekcentrum\/IADA: Amsterdam."},{"key":"BF1301225_CR55","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1176\/appi.ajp.159.4.630","volume":"159","author":"A Kumar","year":"2002","unstructured":"Kumar A, Thomas A, Lavretsky H, Yue K, Huda A, Curran J et al (2002). Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. Am J Psychiatry 159: 630\u2013636.","journal-title":"Am J Psychiatry"},{"key":"BF1301225_CR56","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0967-5868(03)00151-6","volume":"10","author":"GYF Lee","year":"2003","unstructured":"Lee GYF, Gong GWK, Vrodos N, Brophy PB (2003). \u2018Ecstasy\u2019-induced subarachnoid haemorrhage: an under-reported neurological complication? J Clin Neurosci 10: 705\u2013707.","journal-title":"J Clin Neurosci"},{"key":"BF1301225_CR57","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1006\/nimg.1996.0065","volume":"4","author":"JM Levin","year":"1996","unstructured":"Levin JM, Ross MH, Harris G, Renshaw PF (1996). Applications of dynamic susceptibility contrast magnetic resonance imaging in Neuropsychiatry. Neuroimage 4: S147\u2013S162.","journal-title":"Neuroimage"},{"key":"BF1301225_CR58","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0893-133X(99)00071-8","volume":"21","author":"JA Lieberman","year":"1999","unstructured":"Lieberman JA, Aghajanian GK (1999). Caveat emptor: researcher beware. Neuropsychopharmacology 21: 471\u2013473.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301225_CR59","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0893-133X(99)00148-7","volume":"22","author":"ME Liechti","year":"2000","unstructured":"Liechti ME, Baumann C, Gamma A, Vollenweider FX (2000). Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, \u2018ecstasy\u2019) are attenuated by the serotonin uptake inhibitor citalopram. Neuropsychopharmacology 22: 513\u2013521.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301225_CR60","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0924-977X(00)00086-9","volume":"10","author":"ME Liechti","year":"2000","unstructured":"Liechti ME, Vollenweider FX (2000a). Acute psychological and physiological effects of MDMA (\u2018ecstasy\u2019) after haloperidol pretreatment in healthy humans. Eur Neuropsychopharmacol 10: 289\u2013295.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BF1301225_CR61","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/026988110001400313","volume":"14","author":"ME Liechti","year":"2000","unstructured":"Liechti ME, Vollenweider FX (2000b). The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine (\u2018ecstasy\u2019) in healthy volunteers. J Psychopharmacol 14: 269\u2013274.","journal-title":"J Psychopharmacol"},{"key":"BF1301225_CR62","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/nbm.789","volume":"15","author":"KO Lim","year":"2002","unstructured":"Lim KO, Helpern JA (2002). Neuropsychiatric applications of DTI\u2014a review. NMR Biomed 15: 587\u2013593.","journal-title":"NMR Biomed"},{"key":"BF1301225_CR63","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000026665","volume":"42","author":"UD McCann","year":"2000","unstructured":"McCann UD, Eligulashvili V, Ricaurte GA (2000). 3,4-Methylenedioxymethamphetamine (\u2018ecstasy\u2019)-induced serotonin neurotoxicity: clinical studies. Neuropsychobiology 42: 11\u201316.","journal-title":"Neuropsychobiology"},{"key":"BF1301225_CR64","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0893-133X(00)00171-8","volume":"24","author":"UD McCann","year":"2001","unstructured":"McCann UD, Ricaurte GA (2001). Caveat emptor: editors beware. Neuropsychopharmacology 24: 333\u2013336.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301225_CR65","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0140-6736(98)04329-3","volume":"352","author":"UD McCann","year":"1998","unstructured":"McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA (1998). Positron emission tomographic evidence of toxic effect of MDMA (\u2018ecstasy\u2019) on brain serotonin neurons in human beings. Lancet 352: 1433\u20131437.","journal-title":"Lancet"},{"key":"BF1301225_CR66","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1192\/bjp.165.3.391","volume":"165","author":"PK McGuire","year":"1994","unstructured":"McGuire PK, Cope H, Fahy TA (1994). Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine (\u2018ecstasy\u2019). Br J Psychiatry 165: 391\u2013395.","journal-title":"Br J Psychiatry"},{"key":"BF1301225_CR67","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/sj.npp.1300808","volume":"31","author":"A Mechan","year":"2006","unstructured":"Mechan A, Yuan J, Hatzidimitriou G, Irvine RJ, McCann UD, Ricaurte GA (2006). Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons. Neuropsychopharmacology 31: 339\u2013350.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301225_CR68","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/0024-3205(96)00182-8","volume":"58","author":"BL Miller","year":"1996","unstructured":"Miller BL, Chang L, Booth R, Ernst T, Cornford M, Nikas D et al (1996). In vivo1H MRS choline: correlation with in vitro chemistry\/histology. Life Sci 58: 1929\u20131935.","journal-title":"Life Sci"},{"key":"BF1301225_CR69","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/S0140-6736(05)66940-1","volume":"353","author":"JF Morgan","year":"1999","unstructured":"Morgan JF (1999). Toxic effect of MDMA on brain serotonin neurons. Lancet 353: 1268\u20131269.","journal-title":"Lancet"},{"key":"BF1301225_CR70","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0893-133X(98)00012-8","volume":"19","author":"MJ Morgan","year":"1998","unstructured":"Morgan MJ (1998). Recreational use of \u2018ecstasy\u2019 (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19: 252\u2013264.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301225_CR71","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s002130000545","volume":"152","author":"MJ Morgan","year":"2000","unstructured":"Morgan MJ (2000). Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology (Berlin) 152: 230\u2013248.","journal-title":"Psychopharmacology (Berlin)"},{"key":"BF1301225_CR72","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/jnnp.71.2.250","volume":"71","author":"T Murata","year":"2001","unstructured":"Murata T, Kimura H, Kado H, Omori M, Onizuka J, Takahashi T et al (2001). Neuronal damage in the interval form of CO poisoning determined by serial diffusion weighted magnetic resonance imaging plus 1H-magnetic resonance spectroscopy. J Neurol Neurosurg Psychiatry 71: 250\u2013253.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF1301225_CR73","volume-title":"The Revised National Adult Reading Test Manual","author":"HE Nelson","year":"1991","unstructured":"Nelson HE (1991). The Revised National Adult Reading Test Manual. NFER-Nelson: Windsor."},{"key":"BF1301225_CR74","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0925-4927(02)00088-4","volume":"116","author":"TE Nordahl","year":"2002","unstructured":"Nordahl TE, Salo R, Possin K, Gibson DR, Flynn N, Leamon M et al (2002). Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy. Psychiatry Res 116: 43\u201352.","journal-title":"Psychiatry Res"},{"key":"BF1301225_CR75","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0378-4274(01)00511-2","volume":"127","author":"J Obrocki","year":"2002","unstructured":"Obrocki J, Schmoldt A, Buchert R, Andresen B, Petersen K, Thomasius R (2002). Specific neurotoxicity of chronic use of ecstasy. Toxicol Lett 127: 285\u2013297.","journal-title":"Toxicol Lett"},{"key":"BF1301225_CR76","first-page":"105","volume":"60","author":"AC Parrott","year":"2000","unstructured":"Parrott AC, Sisk E, Turner JJD (2000). Psychobiological problems in heavy \u2018ecstasy\u2019 (MDMA) polydrug users. Drug and Alcohol Dependence 60: 105\u2013110.","journal-title":"Drug and Alcohol Dependence"},{"key":"BF1301225_CR77","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/0165-6147(91)90583-E","volume":"12","author":"AA Parsons","year":"1991","unstructured":"Parsons AA (1991). 5-HT receptors in human and animal cerebrovasculature. Trends Pharmacol Sci 12: 310\u2013315.","journal-title":"Trends Pharmacol Sci"},{"key":"BF1301225_CR78","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","volume":"51","author":"JH Patton","year":"1995","unstructured":"Patton JH, Stanford MS, Barratt ES (1995). Factor structure of the Barratt Impulsiveness Scale. Journal of Clinical Psychology 51: 768\u2013774.","journal-title":"Journal of Clinical Psychology"},{"key":"BF1301225_CR79","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/mrm.1910390110","volume":"39","author":"PJ Pouwels","year":"1998","unstructured":"Pouwels PJ, Frahm J (1998). Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med 39: 53\u201360.","journal-title":"Magn Reson Med"},{"key":"BF1301225_CR80","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/mrm.1910300604","volume":"30","author":"SW Provencher","year":"1993","unstructured":"Provencher SW (1993). Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30: 672\u2013679.","journal-title":"Magn Reson Med"},{"key":"BF1301225_CR81","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/S0140-6736(01)06888-X","volume":"358","author":"L Reneman","year":"2001","unstructured":"Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB et al (2001a). Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 358: 1864\u20131869.","journal-title":"Lancet"},{"key":"BF1301225_CR82","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/0269881106061515","volume":"20","author":"L Reneman","year":"2006","unstructured":"Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ (2006). Neuroimaging findings with MDMA\/ecstasy: technical aspects, conceptual issues and future prospects. J Psychopharmacol 20: 164\u2013175.","journal-title":"J Psychopharmacol"},{"key":"BF1301225_CR83","first-page":"1001","volume":"21","author":"L Reneman","year":"2000","unstructured":"Reneman L, Habraken JB, Majoie CB, Booij J, den Heeten GJ (2000). MDMA (\u2018ecstasy\u2019) and its association with cerebrovascular accidents: preliminary findings. AJNR Am J Neuroradiol 21: 1001\u20131007.","journal-title":"AJNR Am J Neuroradiol"},{"key":"BF1301225_CR84","first-page":"231","volume":"23","author":"L Reneman","year":"2002","unstructured":"Reneman L, Majoie CB, Flick H, den Heeten GJ (2002). Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (ecstasy) users: preliminary results. AJNR Am J Neuroradiol 23: 231\u2013237.","journal-title":"AJNR Am J Neuroradiol"},{"key":"BF1301225_CR85","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1148\/radiol.2202001602","volume":"220","author":"L Reneman","year":"2001","unstructured":"Reneman L, Majoie CB, Habraken JB, den Heeten GJ (2001b). Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging. Radiology 220: 611\u2013617.","journal-title":"Radiology"},{"key":"BF1301225_CR86","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0006-3223(01)01177-5","volume":"50","author":"L Reneman","year":"2001","unstructured":"Reneman L, Majoie CB, Schmand B, van den Brink W, den Heeten GJ (2001c). Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report. Biol Psychiatry 50: 550\u2013554.","journal-title":"Biol Psychiatry"},{"issue":"Suppl 5","key":"BF1301225_CR87","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/PL00006895","volume":"7","author":"PF Renshaw","year":"1997","unstructured":"Renshaw PF, Levin JM, Kaufman MJ, Ross MH, Lewis RF, Harris GJ (1997). Dynamic susceptibility contrast magnetic resonance imaging in neuropsychiatry: present utility and future promise. Eur Radiol 7 (Suppl 5): 216\u2013221.","journal-title":"Eur Radiol"},{"key":"BF1301225_CR88","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0006-8993(88)91309-1","volume":"446","author":"GA Ricaurte","year":"1988","unstructured":"Ricaurte GA, DeLanney LE, Irwin I, Langston JW (1988). Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Res 446: 165\u2013168.","journal-title":"Brain Res"},{"key":"BF1301225_CR89","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000026664","volume":"42","author":"GA Ricaurte","year":"2000","unstructured":"Ricaurte GA, Yuan J, McCann UD (2000). 3,4-Methylenedioxymethamphetamine (\u2018ecstasy\u2019)-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42: 5\u201310.","journal-title":"Neuropsychobiology"},{"key":"BF1301225_CR90","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0301-4622(97)00032-X","volume":"68","author":"BD Ross","year":"1997","unstructured":"Ross BD, Bluml S, Cowan R, Danielsen E, Farrow N, Gruetter R (1997). In vivo magnetic resonance spectroscopy of human brain: the biophysical basis of dementia. Biophys Chem 68: 161\u2013172.","journal-title":"Biophys Chem"},{"key":"BF1301225_CR91","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","volume":"1","author":"KJ Rothman","year":"1990","unstructured":"Rothman KJ (1990). No adjustments are needed for multiple comparisons. Epidemiology 1: 43\u201346.","journal-title":"Epidemiology"},{"key":"BF1301225_CR92","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000026667","volume":"42","author":"F Schifano","year":"2000","unstructured":"Schifano F (2000). Potential human neurotoxicity of MDMA (\u2018ecstasy\u2019): subjective self-reports, evidence from an Italian Drug Addiction Centre and clinical case studies. Neuropsychobiology 42: 25\u201333.","journal-title":"Neuropsychobiology"},{"key":"BF1301225_CR93","doi-asserted-by":"crossref","unstructured":"Schilt T, de Win MML, Koeter M, Jager G, Korf DJ, van den Brink W et al (2006). Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Arch Gen Psych (in press).","DOI":"10.1001\/archpsyc.64.6.728"},{"key":"BF1301225_CR94","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/(SICI)1099-1492(200002)13:1<28::AID-NBM606>3.0.CO;2-L","volume":"13","author":"T Schirmer","year":"2000","unstructured":"Schirmer T, Auer DP (2000). On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain. NMR Biomed 13: 28\u201336.","journal-title":"NMR Biomed"},{"key":"BF1301225_CR95","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0006-8993(03)02563-0","volume":"974","author":"LC Schmued","year":"2003","unstructured":"Schmued LC (2003). Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA. Brain Res 974: 127\u2013133.","journal-title":"Brain Res"},{"key":"BF1301225_CR96","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2165\/00003088-200544060-00006","volume":"44","author":"M Segura","year":"2005","unstructured":"Segura M, Farre M, Pichini S, Peiro AM, Roset PN, Ramirez A et al (2005). Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe. Clin Pharmacokinet 44: 649\u2013660.","journal-title":"Clin Pharmacokinet"},{"key":"BF1301225_CR97","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/hbm.10062","volume":"17","author":"SM Smith","year":"2002","unstructured":"Smith SM (2002). Fast robust automated brain extraction. Hum Brain Mapp 17: 143\u2013155.","journal-title":"Hum Brain Mapp"},{"issue":"Suppl 1","key":"BF1301225_CR98","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","volume":"23","author":"SM Smith","year":"2004","unstructured":"Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H et al (2004). Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 (Suppl 1): S208\u2013S219.","journal-title":"Neuroimage"},{"key":"BF1301225_CR99","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.mri.2004.01.028","volume":"22","author":"R Srinivasan","year":"2004","unstructured":"Srinivasan R, Vigneron D, Sailasuta N, Hurd R, Nelson S (2004). A comparative study of myo-inositol quantification using LCmodel at 1.5 T and 3.0 T with 3 D 1H proton spectroscopic imaging of the human brain. Magn Reson Imaging 22: 523\u2013528.","journal-title":"Magn Reson Imaging"},{"key":"BF1301225_CR100","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1177\/070674370204700402","volume":"47","author":"JA Stanley","year":"2002","unstructured":"Stanley JA (2002). In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders. Can J Psychiatry 47: 315\u2013326.","journal-title":"Can J Psychiatry"},{"key":"BF1301225_CR101","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1177\/0269881105048901","volume":"19","author":"HR Sumnall","year":"2005","unstructured":"Sumnall HR, Cole JC (2005). Self-reported depressive symptomatology in community samples of polysubstance misusers who report ecstasy use: a meta-analysis. J Psychopharmacol 19: 84\u201392.","journal-title":"J Psychopharmacol"},{"key":"BF1301225_CR102","unstructured":"The Netherlands National Drug Monitor (2004). Annual Report 2004. Trimbos Institute: Utrecht."},{"key":"BF1301225_CR103","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0893-133X(99)00140-2","volume":"22","author":"F Tuchtenhagen","year":"2000","unstructured":"Tuchtenhagen F, Daumann J, Norra C, Gobbel\u00e9 R, Becker S, Pelz S et al (2000). High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users. Neuropsychopharmacology 22: 608\u2013617.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301225_CR104","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000026669","volume":"42","author":"JJ Turner","year":"2000","unstructured":"Turner JJ, Parrott AC (2000). Is MDMA a human neurotoxin? Diverse views from the discussants. Neuropsychobiology 42: 42\u201348.","journal-title":"Neuropsychobiology"},{"key":"BF1301225_CR105","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/02791072.2001.10400473","volume":"33","author":"G Vaiva","year":"2001","unstructured":"Vaiva G, Boss V, Bailly D, Thomas P, Lestavel P, Goudemand M (2001). An \u2018accidental\u2019 acute psychosis with ecstasy use. J Psychoactive Drugs 33: 95\u201398.","journal-title":"J Psychoactive Drugs"},{"key":"BF1301225_CR106","volume-title":"Ecstasy in het uitgaanscircuit (ecstasy and the Dutch rave scene: A socio-epidemiologic study on the nature and extent of, and the risks involved in using ecstasy and other party drugs at dance events)","author":"G Van de Wijngaart","year":"1997","unstructured":"Van de Wijngaart G, Braam R, de Bruin D, Fris M, Maalst\u00e9 N, Verbraeck H (1997). Ecstasy in het uitgaanscircuit (ecstasy and the Dutch rave scene: A socio-epidemiologic study on the nature and extent of, and the risks involved in using ecstasy and other party drugs at dance events). Addiction Research Institute: Utrecht."},{"key":"BF1301225_CR107","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/sj.npp.1395197","volume":"19","author":"FX Vollenweider","year":"1998","unstructured":"Vollenweider FX, Gamma A, Liechti M, Huber T (1998). Psychological and cardiovascular effects and short-term sequelae of MDMA (\u2018ecstasy\u2019) in MDMA-na\u00efve healthy volunteers. Neuropsychopharmacology 19: 241\u2013251.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301225_CR108","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S0893-133X(99)00032-9","volume":"21","author":"FX Vollenweider","year":"1999","unstructured":"Vollenweider FX, Gamma A, Liechti M, Huber T (1999). Is a single dose of MDMA harmless? Neuropsychopharmacology 21: 598\u2013600.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301225_CR109","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0893-133X(00)00170-6","volume":"24","author":"FX Vollenweider","year":"2001","unstructured":"Vollenweider FX, Jones RT, Baggott MJ (2001). Caveat emptor: editors beware. Neuropsychopharmacology 24: 461\u2013463.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301225_CR110","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00004728-199801000-00027","volume":"22","author":"RP Woods","year":"1998","unstructured":"Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC (1998). Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 22: 139\u2013152.","journal-title":"J Comput Assist Tomogr"},{"key":"BF1301225_CR111","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/1467-6494.00124","volume":"68","author":"M Zuckerman","year":"2000","unstructured":"Zuckerman M, Kuhlman DM (2000). Personality and risk-taking: common biosocial factors. J Pers 68: 999\u20131029.","journal-title":"J Pers"},{"key":"BF1301225_CR112","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1037\/h0026047","volume":"32","author":"M Zuckerman","year":"1968","unstructured":"Zuckerman M, Link K (1968). Construct validity for the sensation-seeking scale. J Consult Clin Psychol 32: 420\u2013426.","journal-title":"J Consult Clin Psychol"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1301225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1301225","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1301225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T05:09:34Z","timestamp":1649912974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1301225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,1]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2,1]]}},"alternative-id":["BF1301225"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1301225","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,1]]},"assertion":[{"value":"21 February 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}